Page 19 - 70_03
P. 19
VOL. 70 (3), 663-679, 2004 PHARMACOKINETICS AND INDIVIDUALIZED DRUG THERAPY
REFERENCES
(1) GIBALDI, M.; PERRIER, D. (1975) In Pharmacokinetics, Marcel Dekker Inc, New
York.
(2) TEORELL, T. (1937) Kinetics of distribution of substances administered to the
body I. The extravascular modes of administration. Arch. Int. Pharmacodyn.
57: 205.
(3) TEORELL, T. (1937) Kinetics of distribution of substances administered to the
body I. The extravascular modes of administration. Arch. Int. Pharmacodyn.
57: 226.
(4) ROWLAND, M.; TOZER, T.N. (1995) In Clinical Pharmacokinetics, Concepts and
applications 3rd ed. Williams & Wilkens, Baltimore.
(5) EVANS, W.E., SCHENTAG, J.J.; JUSKO, W.J. (1992) In Applied Pharmacokinetics.
Principles of Therapeutic Drug Monitoring 3rd ed. Applied Therapeutics, Inc.,
Vancouver.
(6) PAALZOW, L. (1990) Pharmacodynamics, pp. 333-358. In: Taylor, J.B. ed. Com-
prehensive Medical Chemistry, Vol. 5, Biopharmaceutics. Pergamon Press,
Oxford.
(7) SHEINER, L.B.; ROSENBERG, B.; MELMON, K.L. (1972) Modelling of individual
pharmacokinetics for computer aided drug dosage. Comp. Biochem. Res. 5:
441-459.
(8) PAALZOW, L.K.; PAALZOW, G.H.M.; TFELT-HANSEN, P. (1985) Variability in Bio-
availability: Cencentration versus Effect. In Rowland, M,; Sheiner, L.B.; Stei-
mer, J-L. (eds): Variability in Drug Therapy, Description, Estimation, and
Control. Raven Press, New York.
679
